Search Results 21-30 of 12321 for MOD-4023

1. https://www.mayoclinic.org/chinese_patient_consumer_faq.xml

   ... <lastmod>2026-02-27T16:14:42-06:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/diseases-conditions/multiple ...

2. https://www.mayoclinic.org/condition_consolidated_concepts.xml

   ... <lastmod>2024-06-18T21:31:52-05:00</lastmod><xhtml:link rel="alternate" hreflang="es" href="https://www.mayoclinic.org/es/diseases-conditions/congenital ...

3. A Study Of SAR442085 In Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   About this study. The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with ...

4. https://www.mayoclinic.org/~/media/0439A7376021433E8FB3180F95C8FF95

   ... <lastmod>2016-08-07T07:13:34-07:00</lastmod> </url> <url> <loc>http://www.mayoclinic.org/2-d-fetal-ultrasound/img-20005776</loc> <lastmod>2016-08-07T07:13 ...

5. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

   ... <lastmod>2024-08-12T18:50:31-05:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/diseases-conditions/congenital-heart ...

6. Bezlotoxumab (MK-6072) Versus Placebo In Children With Clostridium Difficile Infection (CDI) (MK-6072-001) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. https://www.mayoclinic.org/arabic_patient_consumer_faq.xml

   ... <lastmod>2025-12-08T15:38:20-06:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis ...

8. https://www.mayoclinic.org/patient_consumer_faq.xml

   ... <lastmod>2024-09-30T18:41:00-05:00</lastmod><xhtml:link rel="alternate" hreflang="es" href="https://www.mayoclinic.org/es/diseases-conditions/multiple ...

9. https://www.mayoclinic.org/spanish_condition_consolidated_concepts.xml

   ... <lastmod>2024-08-29T17:35:48-05:00</lastmod><xhtml:link rel="alternate" hreflang="en" href="https://www.mayoclinic.org/diseases-conditions/congenital-heart ...

10. A Long-term Active Treatment Study Of Mongersen (GED-0301) In Subjects With Crohn's Disease - Mayo Clinic

    About this study. The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ...